Impact of Covid-19 in the Emergency Department

Impact of Covid-19 in the Emergency Department in a Tertiary Care Hospital, Nuremberg-Germany

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05150821

Enrollment

599

Registered

2021-12-09

Start date

2020-09-01

Completion date

2023-07-01

Last updated

2023-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

To investigate the effects of lockdown in the Emergency Department in a tertiary health care hospital, Nuremberg, Germany.

Detailed description

To investigate the effect of the first lockdown caused by the pandemic of Covid-19 in a tertiary health care hospital. Klinikum Nuremberg is one of the largest tertiary health care hospitals in Germany with two locations in Nuremberg. In the north department, around 150 outcome patients visit the Emergency Department every day. During the pandemic in 2020 the capacities of the hospitals were saved for the patients with Covid-19. A decrease of patients presented in the ED was noticed. Controlling system and patient management provided the number of cases and correlated with the same period of time one year ago, before the pandemic. For the classification of severity of diseases, different clinical diseases with severity scores were analyzed. Following diseases and scores were evaluated: Pancreatitis -- \> ranson score; ACS (acute coronary syndrome) --\> Grace-Score; Pulmonary Embolism -- \> sPESI (simplified Pulmonary Embolism Severity Index); Diverticulitis --\> CDD (Classification of Diverticular Disease); Pneumonia -\> crb65 (Confusion- Respiratory rate- Blood pressure- age ≥ 65 years);

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Only patients who presented in the ED.

Exclusion criteria

none

Design outcomes

Primary

Measure	Time frame	Description
ranson score	through study completion, an average of 1 year	clinical severity index of pancreatitis. Estimates mortality of patients with pancreatitis, based on initial and 48-hour lab values. Min. 0 - Max. 11 points.
Grace-Score	through study completion, an average of 1 year	clinical severity index of ACS. Estimates admission untill 6 month mortality for patients with acute coronary syndrome. 108 points: low risk. Over 141-372 points: high risk.
sPESI	through study completion, an average of 1 year	clinical severity index of pulmonary embolism. Predicts 30-day outcome of patients with pulmonary embolism. Min 0 points- max. 6 points
crb65	through study completion, an average of 1 year	The CRB-65-score is a clinical score that is used to estimate the severity of community-acquired pneumonias. The score corresponds to the statistical probability of patients dying because of pneumonia. Min 0 points - highest score 4 points.
CDD	through study completion, an average of 1 year	clinical severity index of diverticulitis. Min 0 - max. 4

Countries

Germany

Outcome results